The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond ...

Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Recent research shows up to 40% of dementia cases could be prevented. Europe needs a cross-border policy rethink to impact ...

Any upgrade to animal rights should be welcome Tuckahoe, N.Y.: How sad that the Daily News chose to take aim at a court decision that might have significantly helped the plight of animals, who are the ...

Astute Analytica stands out as a premier provider of comprehensive Automated Immunoassay Analyzers market research reports specifically tailored for the healthcare sector. Our commitment lies in ...